And, pending approval, Zymeworks is eligible to receive tiered royalties between 10% and 20% on Jazz’s net sales. Zanidatamab is an HER2-targeted bispecific antibody with multiple novel ...
Since the start of the year, Ipsen has bolstered its oncology pipeline with two ADC alliances – with Foreseen Bio and Sutro ...
BEIJING, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics, ...
After hours: November 29 at 4:37 PM EST Loading Chart for ZYME ...
At close: December 2 at 4:00 PM EST ...
Together, these hormones regulate body temperature, heart rate, and metabolism. They also promote growth, development, and maturation of the brain and nervous system. Antibodies serve a purpose in ...
Aa Aaaa Aa 123.64 +34.98% ...